Tower Research Capital (TRC)’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Other funds holding PROF
TIM
GA
MI
Tower Research Capital (TRC)'s PROF Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Profound Medical (PROF) stake by 85% in Q3 2026, buying an estimated $9.1K and bringing the position to 2,923 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #3894.
Tower Research Capital (TRC) first reported a position in PROF in Q1 2021 and has held it in 14 quarters since. The position peaked at $39.1K in Q2 2023. 57 funds tracked by Wall St. Rank hold PROF as of Q3 2026.
- Tower Research Capital (TRC) held 2,923 shares of Profound Medical worth $17K as of Q3 2026.
- Tower Research Capital (TRC) bought 1,339 Profound Medical shares in Q3 2026, an estimated $9.1K.
- Profound Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3894 holding.
- Tower Research Capital (TRC) first reported a position in Profound Medical in Q1 2021 and has held it in 14 quarters since.
- Tower Research Capital (TRC)'s Profound Medical position peaked at $39.1K in Q2 2023.
- 57 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.